Ryan is Vice President of Strategy and Business Development. A serial company builder, Ryan has operated in multiple strategy and business development roles at both startups and large Pharma companies. Prior to joining Xilis, Ryan lead strategy and business development at Herophilus, a neuroscience drug discovery startup that built a patient-derived brain organoid drug discovery platform and was acquired by Genentech in 2023. Ryan also coordinated ADC search and evaluation at Stemcentrx following its acquisition by AbbVie, and lead post-acquisition integration of Stemcentrx' partnering activities into AbbVie's corporate strategy office. Ryan has a PhD in neuroscience from the David Geffen School of Medicine at UCLA.
